These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33923427)

  • 21. Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas.
    Ishikawa M; Fujii T; Masumoto N; Saito M; Mukai M; Nindl I; Ridder R; Fukuchi T; Kubushiro K; Tsukazaki K; Nozawa S
    Int J Gynecol Pathol; 2003 Oct; 22(4):378-85. PubMed ID: 14501820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The p16INK4A mRNA transcripts estimation in cervical smear with different degrees of cervical dysplasia].
    Janušicová V; Kapustová I; Zúbor P; Slezák P; Kajo K; Lasabová Z; Plank L; Danko J
    Ceska Gynekol; 2012 Jun; 77(3):245-50. PubMed ID: 22779728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
    Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
    Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
    Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
    Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
    Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
    Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
    Walts AE; Lechago J; Bose S
    Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunohistochemical detection of P16 and HPV L1 capsid protein on cell block sections from residual PapSpin liquid-based gynecology cytology specimens as a diagnostic and prognostic tool.
    Haltas H; Bayrak R; Yenidunya S; Yildirim U
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1588-95. PubMed ID: 23111976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.
    Keating JT; Cviko A; Riethdorf S; Riethdorf L; Quade BJ; Sun D; Duensing S; Sheets EE; Munger K; Crum CP
    Am J Surg Pathol; 2001 Jul; 25(7):884-91. PubMed ID: 11420459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers V: Recommendations on the Use of Immunohistochemical and Molecular Biomarkers in Penile Cancer.
    Canete-Portillo S; Velazquez EF; Kristiansen G; Egevad L; Grignon D; Chaux A; Cubilla AL
    Am J Surg Pathol; 2020 Jul; 44(7):e80-e86. PubMed ID: 32235153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
    Clark JL; Lu D; Kalir T; Liu Y
    Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk HPV E6/E7 mRNA in situ hybridization in endocervical glandular neoplasia: performance compared with p16
    Chen T; Li J; Wang S; Ning Y; Zhou X; Wang Y
    Am J Transl Res; 2019; 11(10):6498-6506. PubMed ID: 31737201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma.
    Missaoui N; Hmissa S; Frappart L; Trabelsi A; Ben Abdelkader A; Traore C; Mokni M; Yaacoubi MT; Korbi S
    Virchows Arch; 2006 May; 448(5):597-603. PubMed ID: 16496173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
    Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
    BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p16INK4A overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women.
    Missaoui N; Trabelsi A; Hmissa S; Fontanière B; Yacoubi MT; Mokni M; Korbi S; Frappart L
    Pathol Res Pract; 2010 Aug; 206(8):550-5. PubMed ID: 20400236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Usefulness of p16 Immunohistochemistry for some Epithelial Lesions in the Pathology Service of Sultan Qaboos University Hospital.
    Al-Ghafri I; Al-Husseini S; Al-Rashdi A; Arafa M
    Maedica (Bucur); 2021 Dec; 16(4):634-641. PubMed ID: 35261666
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors.
    Buza N
    Semin Diagn Pathol; 2022 Jan; 39(1):58-77. PubMed ID: 34750021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Molecular Classification on Treatment Paradigms in Uterine Cancers.
    Cosgrove CM; Barrington D; Backes FJ
    Curr Oncol Rep; 2021 May; 23(7):75. PubMed ID: 33937919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.